To sum up, the FGRs CDKN1A and SIRT1 may regulate the progression of NASH through ferroptosis and serve as molecular diagnostic markers and drug targets. The gene discussed is CDKN1A; the disease is metabolic dysfunction-associated steatohepatitis.